Union

Mainz Biomed Announces Year End 2021 Results

Retrieved on: 
Wednesday, March 9, 2022
CRO, IPO, Exercise, Partnership, Colorectal cancer, U.S. Securities and Exchange Commission, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, IVDR, CMS, Private Securities Litigation Reform Act, Health, Mission statement, Growth, Union, AA, Biomarker, Compliance, Company, Prospectus, Colon, FDA, LLC, DNA, American Cancer Society, GLOBE, Patient, MDPI, Nutritionist, Contract research organization, Death, SEC, Review, Center, Laboratory, NASDAQ, Real-time polymerase chain reaction, PCR, Physician, Cancer, FIT, Gene expression, Security (finance), Neoplasm, Forward-looking statement, Nasdaq, Ageing, Trial of the century, Large intestine, GD, Labour, COVID-19, Food, CRC, Vaccine, Pharmaceutical industry, Cryptocurrency, Medicine, EU

BERKELEY, Calif. and MAINZ, Germany, March 09, 2022 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (Mainz Biomed or the Company), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today key strategic and operational results for the year ended December 31, 2021.

Key Points: 
  • BERKELEY, Calif. and MAINZ, Germany, March 09, 2022 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (Mainz Biomed or the Company), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today key strategic and operational results for the year ended December 31, 2021.
  • In December 2021, Mainz commenced its differentiated commercial plan of partnering with third-party laboratories for test kit processing versus the traditional methodology of operating a single facility.
  • The Company expects to complete enrolment during the second half of 2022 and is targeting reporting study results in early 2023.
  • In November 2021, Mainz executed a successful IPO onto Nasdaq raising $11.5 million by placing 2,300,000 common shares at a public offering price of $5.00 per share.

Cue Health to Announce Fourth Quarter and Full-Year 2021 Financial Results

Retrieved on: 
Tuesday, March 8, 2022
Technology, Hospitals, Telecommunications, Software, Practice Management, Internet, Health, General Health, Data Management, Nasdaq, Health Canada, Webcast, FDA, Telephone, Central Drugs Standard Control Organisation, Health, Cue, Hand, PSAR, Interest, COVID-19, CE, Health Sciences Authority, Interim order, Union, Pharmaceutical industry

Cue Health (Cue) (Nasdaq: HLTH), a healthcare technology company, announced today that it will release its fourth quarter and full-year 2021 financial results on Tuesday, March 29, 2022.

Key Points: 
  • Cue Health (Cue) (Nasdaq: HLTH), a healthcare technology company, announced today that it will release its fourth quarter and full-year 2021 financial results on Tuesday, March 29, 2022.
  • In conjunction with the release, Cue will host a conference call and webcast that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights.
  • Cue Health (Nasdaq: HLTH) is a healthcare technology company that makes it easy for individuals to access health information and places diagnostic information at the center of care.
  • Cue Health enables people to manage their health through real-time, actionable, and connected health information, offering individuals and their healthcare providers easy access to lab-quality diagnostics anywhere, anytime, in a device that fits in the palm of the hand.

The Chianti Classico Grand Tasting In New York Concludes With a Great Success And Celebration of the Newly Introduced UGA Classification System

Retrieved on: 
Tuesday, March 8, 2022
Wine, Black Rooster (EP), DOCG, Research, GS, Bulldog, Altmann, Chianti, Gran, Tuscan wine, Consortium, The Pick of Destiny, UGA, COVID-19, Union, Awareness, Mobile phone, Tourism, Gaiole in Chianti

This system was introduced to strengthen the relationship between Chianti Classico wines and their unique territorial origins, reinforcing quality and local identity.

Key Points: 
  • This system was introduced to strengthen the relationship between Chianti Classico wines and their unique territorial origins, reinforcing quality and local identity.
  • The media seminar was accompanied by the tasting of 11 Chianti Classico Gran Selezione, representing the 11 UGA villages.
  • "The introduction of the additional geographical units (UGA) that divide the Chianti Classico territory into more specific areas represents an epochal turning point for the denomination.
  • About the Consorzio Vino Chianti Classico:
    The Consorzio Vino Chianti Classico exists to protect, oversee, and valorize the Chianti Classico denomination.

DGAP-News: BANK OF SCOTLAND PLC ANNUAL REPORT AND ACCOUNTS FOR THE YEAR ENDED 31 DECEMBER 2021

Retrieved on: 
Tuesday, March 8, 2022
Bank, Financial Conduct Authority, Government, United Kingdom, Risk, Instability, Lloyds Banking Group, Disaster, Terrorism, Failure, Annual report, ESG, U.S. Securities and Exchange Commission, Hinterland (TV series), Hostility, Policy, RNS, DGAP, London Stock Exchange, Climate change, News, Vicente Lopez Ibor Mayor, London, Uncertainty, Mission statement, Cooperation, Lloyds Bank, Bank of Scotland, SEC, Union, Probability, Goal, Insurance, US, Eurozone, EU, Group, COVID-19

Statements that are not historical or current facts, including statements about the Group's or its directors' and/or management's beliefs and expectations, are forward looking statements.

Key Points: 
  • Statements that are not historical or current facts, including statements about the Group's or its directors' and/or management's beliefs and expectations, are forward looking statements.
  • By their nature, forward looking statements involve risk and uncertainty because they relate to events and depend upon circumstances that will or may occur in the future.
  • RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
  • The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

2021 Form 20F Filed

Retrieved on: 
Tuesday, March 8, 2022
Financial Conduct Authority, Government, Lloyds Banking Group, United Kingdom, Lloyds Bank, Risk, Instability, Disaster, Terrorism, Failure, Annual report, ESG, U.S. Securities and Exchange Commission, Hinterland (TV series), Hostility, Policy, RNS, London Stock Exchange, Climate change, Vicente Lopez Ibor Mayor, London, Uncertainty, Mission statement, Cooperation, SEC, Union, Probability, Goal, Insurance, US, Bank, Medicine, Eurozone, EU, COVID-19

Statements that are not historical or current facts, including statements about the Lloyds Bank Group's or its directors' and/or management's beliefs and expectations, are forward looking statements.

Key Points: 
  • Statements that are not historical or current facts, including statements about the Lloyds Bank Group's or its directors' and/or management's beliefs and expectations, are forward looking statements.
  • By their nature, forward looking statements involve risk and uncertainty because they relate to events and depend upon circumstances that will or may occur in the future.
  • Please refer to the latest Annual Report on Form 20-F filed by Lloyds Bank plc with the US Securities and Exchange Commission (the SEC), which is available on the SEC's website at www.sec.gov, for a discussion of certain factors and risks.
  • RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.

2021 Annual Report and Accounts

Retrieved on: 
Tuesday, March 8, 2022
Financial Conduct Authority, Government, Lloyds Banking Group, United Kingdom, Lloyds Bank, Risk, Instability, Disaster, Terrorism, Failure, Annual report, ESG, U.S. Securities and Exchange Commission, Hinterland (TV series), Hostility, Policy, RNS, London Stock Exchange, Climate change, Vicente Lopez Ibor Mayor, London, Uncertainty, Mission statement, Cooperation, SEC, Union, Probability, Goal, Insurance, US, Bank, Medicine, Eurozone, EU, COVID-19

LONDON, March 08, 2022 (GLOBE NEWSWIRE) -- In accordance with Listing Rule 9.6.1, Lloyds Bank plc has submitted today the above document to the National Storage Mechanism.

Key Points: 
  • Statements that are not historical or current facts, including statements about the Lloyds Bank Group's or its directors' and/or management's beliefs and expectations, are forward looking statements.
  • By their nature, forward looking statements involve risk and uncertainty because they relate to events and depend upon circumstances that will or may occur in the future.
  • Please refer to the latest Annual Report on Form 20-F filed by Lloyds Bank plc with the US Securities and Exchange Commission (the SEC), which is available on the SEC's website at www.sec.gov, for a discussion of certain factors and risks.
  • RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.

Panbela Schedules Conference Call on March 24, 2022, to Report 2021 Fourth Quarter Financial Results

Retrieved on: 
Tuesday, March 8, 2022
Risk, Private Securities Litigation Reform Act, File, Bone marrow suppression, Patient, Peripheral neuropathy, PMI, Forward-looking statement, Safety, Annual report, Nasdaq, Pancreatic cancer, FDA, Therapy, ORR, Retinal detachment, Neoplasm, Clinical trial, Ovarian cancer, Union, Cancer, Retinopathy, Pharmaceutical industry

In data evaluated from clinical studies to date, SBP-101 has not shown exacerbation of bone marrow suppression and peripheral neuropathy, which can be chemotherapy-related adverse events.

Key Points: 
  • In data evaluated from clinical studies to date, SBP-101 has not shown exacerbation of bone marrow suppression and peripheral neuropathy, which can be chemotherapy-related adverse events.
  • The safety data and PMI profile observed in the current Panbela sponsored clinical trial provides support for continued evaluation of SBP-101 in a randomized clinical trial.
  • Panbela Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing disruptive therapeutics for patients with urgent unmet medical needs.
  • Our actual results and financial condition may differ materially and adversely from the forward-looking statements.

Quotient Limited Announces Receipt of CE Mark for the Extended Immunohematology Microarray

Retrieved on: 
Tuesday, March 8, 2022
Risk, ABO, CE marking, Private Securities Litigation Reform Act, European Medical Devices Industry Group, Security (finance), Laboratory, Securities Exchange Act of 1934, Infection, News, U.S. Securities and Exchange Commission, Solution, Growth, Â, Company, COVID-19, Securities Act of 1933, Marketing, IH, Workflow, CE, Union, Extension, GLOBE, NASDAQ, Physician, Medical device, Quotient

The CE marking confirms the Extended IH Microarray meets the requirements of the European Medical Devices Directive.

Key Points: 
  • The CE marking confirms the Extended IH Microarray meets the requirements of the European Medical Devices Directive.
  • This allows the Company to commercialize the microarray for use with the Company's MosaiQ instrument across the European Union and other CE Mark recognizing geographies.
  • The IH microarray for which the CE mark was just obtained substantially increases the range of tests that can be run on the platform.
  • The Quotient logo, Quotient MosaiQ and MosaiQ are registered trademarks or trademarks of Quotient Limited and its subsidiaries in various jurisdictions.

Global Coupled Inductor Market (2021 to 2026) - Featuring Coilcraft, Vishay Intertechnology and Wurth Electronics Among Others - ResearchAndMarkets.com

Retrieved on: 
Tuesday, March 8, 2022
Technology, Energy, Other Energy, Consumer Electronics, Adoption, Investment, Industry, Field line, Automation, Income, Internet, Government, Growth, Artificial intelligence, Efficiency, Sale, COVID-19, Unemployment, Car, Electronics, Radio frequency, Union, IOT, Carbon, Electronic component

Due to their cost-effectiveness and reduced space requirements, coupled inductors are becoming more popular in consumer electronics and the automotive industry.

Key Points: 
  • Due to their cost-effectiveness and reduced space requirements, coupled inductors are becoming more popular in consumer electronics and the automotive industry.
  • Radiofrequency identification, transformers, wireless power transfers, electric motors, and generators, as well as induction cookers, and induction heating systems, all require coupled inductors.
  • The rising electronics sector is projected to boost the global coupled inductor market forward.
  • These restrictions not only hindered the operations of the global coupled inductor market players but also its end-use industries like industrial machinery and automotive among others.

Aegon provides update on Russian and Belarusian investments following invasion of Ukraine

Retrieved on: 
Tuesday, March 8, 2022
International Association of Insurance Supervisors, Failure, United Kingdom, International Association, Market share, Longevity, Policy, Financial Stability Board, Government, Disease, Organization, Financial market, Annual report, Holding, Cyprus Securities and Exchange Commission, Information technology, Pandemic, Public opinion, Terrorism, Writing, Finance, Catastrophe, Nature, Mortality, Netherlands Authority for the Financial Markets, Insurance, Union, Pension, Risk management, Public utility, Security (finance), Bank, Reinsurance, Cryptocurrency, EU, Aegon, European

These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict.

Key Points: 
  • These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict.
  • Aegon undertakes no obligation to publicly update or revise any forward-looking statements.
  • Readers are cautioned not to place undue reliance on these forward-looking statements, which merely reflect company expectations at the time of writing.
  • Actual results may differ materially from expectations conveyed in forward-looking statements due to changes caused by various risks and uncertainties.